Professional Documents
Culture Documents
DRESS Syndrome
Drug Reacton/Rash with Eosinophilia and Systemic Symptoms HSS: Hypersensitivity Syndrome DIHS: Drug-Induced Hypersensitivity Syndrome DIDMOHS: Drug-Induced Delayed Multiorgan Hypersensitivity Syndrome
Presentation
Maculopapular rash developing 2-6 weeks after starting the medication. Fever Leukocyte abnormalities: Leukocytosis, atypical lymphocytosis, eosinophilia Liver or other organ abnormalities Lymphadenopathy
Common causes
Anticonvulsants
Organ involvement
Hematologic abnormalities
Atypical lymphocytes 63% Eosinophilia 52% Lymphocytopenia 45% Thrombocytopenia 25% Lymphocytosis 25%
Diagnosis
Hospitalization Reaction suspected to be drug-related Acute rash Fever>38 Lymphadenopathy in at least two sites Involvement of at least one internal organ Blood count abnormalities (lymphopenia, lymphocytosis, eosinophilia, thrombocytopenia)
Diagnosis
Maculopauplar rash developing > 3 wks after starting the suspected drug Prolonged symptoms 2 wks after stopping the drug Fever >38 Liver abnormalities or other organ involvement Leukocyte abnormalities Leukocytosis Atypical lymphocytosis Lymphadenopathy Human herpesvirus 6 reactivation
Diagnosis
Clinical diagnosis. Broad differential. Differing criteria for diagnosis. Biopsy can help, but is not necessary or specific.
Treatment
Antihistamines Topical steroids Help with symptoms Unknown if alters long-term prognosis No randomized trials
Systemic corticosteroids
IVIG
Prognosis
10% mortality
Pathogenesis
Sources
Seth, Divya MD, Kamat, Deepak MD, and Jenny Montejo, MD. DRESS Syndrome: A Practical Approach for Primary Care Practitioners. Clinical Pediatrics. 2008; 47:947952. Tables obtained from Wikipedia: (Originals from Chen YC, Chiu HC, Chu C?Y.Drug Reaction with Eosiniphilia and Systemic Symptoms: A retrospective study of 60 cases. Arch Dermatol. 2010; 146: 1373-1379). Up-to-date. Drug allergy: Classification and clinical features. Walsh, SA and D Creamer. Drug reaction with eosinophilia and systemic symtpoms: a clinical update and review of current thinking. Clinical Dermatology. 2010; 36:6-11.